' End of the Road ' for Trabectedin in Ovarian Cancer?

(MedPage Today) -- Trial stopped for futility, but 13-month OS improvement seen in patients with BRCA mutations
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news